Chapter
Melatonin’s Benefits as a Treatment for COVID-19 Pandemic and Long COVID
Abstract
Melatonin has been recognized for its therapeutic potential as a chronobiotic cytoprotective drug to combat the effects of COVID-19 infection. Melatonin may be unique in mitigating the symptoms of SARS-CoV-2 infection due to its wide-ranging actions as an antioxidant, anti-inflammatory, and immunomodulatory chemical. Furthermore, melatonin is an efficient chronobiotic drug in treating delirium and reversing the circadian disturbance caused by …
Authors
Cardinali DP; Brown GM; Pandi-Perumal SR
Book title
COVID-19 and Sleep: A Global Outlook
Series
Progress in Sleep Research
Pagination
pp. 385-403
Publisher
Springer Nature
Publication Date
2023
DOI
10.1007/978-981-99-0240-8_24